title: JAK2V617F mutational status and allele burden have little influence on clinical phenotype and prognosis in patients with post-polycythemia vera and post-essential thrombocythemia myelofibrosis.
authors.forename: Paola
authors.initials: P
authors.lastname: Guglielmelli
authors.forename: Giovanni
authors.initials: G
authors.lastname: Barosi
authors.forename: Lisa
authors.initials: L
authors.lastname: Pieri
authors.forename: Elisabetta
authors.initials: E
authors.lastname: Antonioli
authors.forename: Alberto
authors.initials: A
authors.lastname: Bosi
authors.forename: Alessandro M
authors.initials: AM
authors.lastname: Vannucchi
mesh_terms: D000328:Adult; D000368:Aged; D000483:Alleles; D005260:Female; D006801:Humans; D053614:Janus Kinase 2 / Q000235:genetics / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D009154:Mutation / Q000235:genetics; D010641:Phenotype; D011087:Polycythemia Vera / Q000201:enzymology* / Q000235:genetics / Q000473:pathology*; D011379:Prognosis; D013920:Thrombocythemia, Essential / Q000201:enzymology* / Q000235:genetics / Q000473:pathology*; D014633:Valine / Q000235:genetics / Q000378:metabolism
chemical_list: C507924:JAK2 protein, human; D053614:Janus Kinase 2; D014633:Valine